当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析

凯赛生物

(688065)

  

流通市值:275.35亿  总市值:340.45亿
流通股本:5.83亿   总股本:7.21亿

凯赛生物(688065)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.24亿元,每股收益0.23元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益2114531.57万元,未分配利润244350.85万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产2468986.84万元,负债354455.27万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入775,769,935.752,957,911,554.762,215,083,356.31,444,292,958.19
营业总成本619,368,581.392,361,273,032.481,806,773,748.371,153,083,688.62
营业利润161,685,700.77551,561,171.61389,098,019.4280,514,424.87
利润总额158,040,889.01548,015,229.03387,371,747.02280,867,987.8
净利润124,318,691.92474,589,331.67338,433,720.91244,107,412.58
其他综合收益3,862,477.8-5,486,780.85216,838.63-2,793,036.93
综合收益总额128,181,169.72469,102,550.82338,650,559.54241,314,375.65
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计12,947,798,435.287,386,914,396.786,812,364,351.976,827,315,489.34
非流动资产合计11,742,069,967.911,634,562,952.8611,517,671,650.7611,495,376,904.67
资产总计24,689,868,403.1819,021,477,349.6418,330,036,002.7318,322,692,394.01
流动负债合计2,538,495,884.892,917,855,546.032,374,106,190.42,454,447,009.6
非流动负债合计1,006,056,817.11,002,549,593.88966,745,562.18977,655,951.1
负债合计3,544,552,701.993,920,405,139.913,340,851,752.583,432,102,960.7
归属于母公司股东权益合计17,563,815,224.8111,507,005,495.2511,386,757,208.8711,284,837,279.05
股东权益合计21,145,315,701.1915,101,072,209.7314,989,184,250.1514,890,589,433.31
负债和股东权益合计24,689,868,403.1819,021,477,349.6418,330,036,002.7318,322,692,394.01
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计744,764,366.483,351,448,965.932,455,832,300.561,608,127,866.85
经营活动现金流出小计657,274,979.572,530,519,633.511,779,816,342.831,172,669,454.66
经营活动产生的现金流量净额87,489,386.91820,929,332.42676,015,957.73435,458,412.19
投资活动现金流入小计-20,252,268.7430,046,19930,000,000
投资活动现金流出小计305,227,020.78843,313,170.45643,949,366.3564,671,303.37
投资活动产生的现金流量净额-305,227,020.78-823,060,901.71-613,903,167.3-534,671,303.37
筹资活动现金流入小计6,293,622,576.951,889,290,806.481,295,208,915.31,295,208,915.3
筹资活动现金流出小计628,364,962.171,739,798,822.611,708,887,914.211,588,725,494.28
筹资活动产生的现金流量净额5,665,257,614.78149,491,983.87-413,678,998.91-293,516,578.98
汇率变动对现金及现金等价物的影响2,366,523.9924,824,735.62-28,144,057.3610,726,976.8
现金及现金等价物净增加额5,449,886,504.9172,185,150.2-379,710,265.84-382,002,493.36
期末现金及现金等价物余额10,635,851,218.025,185,964,713.124,634,069,297.084,631,777,069.56
最新报告期:2025-04-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
申万宏源周超,宋涛,马昕晔0.901.131.402025-04-30
国海证券李永磊,董伯骏1.011.181.462025-04-30
长城证券王彤,肖亚平0.931.181.412025-04-28
中信证券李超,王喆0.710.841.132025-04-25
西部证券黄侃0.931.151.302025-04-23
TOP↑